{"id":77041,"date":"2022-04-05T00:00:00","date_gmt":"2022-04-05T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2022\/04\/05\/risk-for-atrial-fibrillation-recurrence-increases-with-body-weight\/"},"modified":"2022-04-07T17:11:52","modified_gmt":"2022-04-07T17:11:52","slug":"risk-for-atrial-fibrillation-recurrence-increases-with-body-weight","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/04\/05\/risk-for-atrial-fibrillation-recurrence-increases-with-body-weight\/","title":{"rendered":"Risk for Atrial Fibrillation Recurrence Increases With Body Weight"},"content":{"rendered":"<h3>\n<p>Body mass index linked to both short- and long-term risk for return of the heart rhythm disorder following ablation<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, April 5, 2022 (HealthDay News) &#8212; Rates of atrial fibrillation (AF) recurrence following ablation increase incrementally according to body mass index, both in short- and long-term follow-up, according to a study presented at the annual meeting of the European Heart Rhythm Association, held from April 3 to 5 in Copenhagen, Denmark.<\/p>\n<p>Jacob Toennesen, M.B.B.S., from Gentofte University Hospital in Denmark, and colleagues used Danish registries to identify all adult patients (9,229 individuals) who underwent first-time AF ablation from 2010 through 2018. Relative rates of AF recurrence were examined by body weight.<\/p>\n<p>The researchers found that the median age at first-time AF ablation was lower in the morbidly obese group (60 years) than in the normal-weight group (64 years). The number of patients with a CHA\u00e2\u0082\u0082DS\u00e2\u0082\u0082VASc score \u00e2\u0089\u00a52 was higher in the morbidly obese group (65 percent) than in the normal-weight group (48 percent). Both at one-year and five-year follow-up, the risk for recurrent AF increased incrementally and significantly in overweight groups versus normal-weight patients.<\/p>\n<p>&#8220;The strength of association between high body mass index and repeat atrial fibrillation after ablation was comparable to the influence of well-known factors like heart failure, chronic obstructive pulmonary disease, and hypertension which are typically treated in these patients,&#8221; Toennesen said in a statement. &#8220;Our study suggests that overweight patients should be advised to lose weight before the intervention to improve the likelihood of being free of the arrhythmia afterwards.&#8221;<\/p>\n<p>The study was supported by Novo Nordisk.<\/p>\n<p><a href=\"https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/Overweight-patients-should-slim-down-before-procedure-to-treat-abnormal-heart-rhythm\" target=\"_blank\" rel=\"noopener\">Press Release<\/a> <\/p>\n<p><a href=\"https:\/\/www.escardio.org\/Congresses-&#038;-Events\/EHRA-Congress\" target=\"_blank\" rel=\"noopener\">More Information<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Body mass index linked to both short- and long-term risk for return of the heart rhythm disorder following ablation<\/p>\n","protected":false},"author":6,"featured_media":77311,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-77041","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/77041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=77041"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/77041\/revisions"}],"predecessor-version":[{"id":77214,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/77041\/revisions\/77214"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/77311"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=77041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=77041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=77041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}